Sequential Combination Chemotherapy of Dacarbazine (DTIC) with Carboplatin and Paclitaxel for Patients with Metastatic Mucosal Melanoma of Nasal Cavity and Paranasal Sinuses

By the recent introduction of molecular targeting drugs against BRAF mutation and immune checkpoint inhibitors, the prognosis of patients with melanoma in advanced stage is now improving, but still in the minority. Mucosal melanoma lacks the BRAF mutations, and hence conventional chemotherapeutic re...

Descripción completa

Detalles Bibliográficos
Autores principales: Omata, W., Tsutsumida, A., Namikawa, K., Takahashi, A., Oashi, K., Yamazaki, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224238/
https://www.ncbi.nlm.nih.gov/pubmed/28096700
http://dx.doi.org/10.4137/CCRep.S39851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224238/
https://www.ncbi.nlm.nih.gov/pubmed/28096700
http://dx.doi.org/10.4137/CCRep.S39851

Ejemplares similares